Accessibility options
Translate the page
The Barts Life Sciences Cluster Launches in Whitechapel, East London
With planned investment of over £800m, the Cluster brings together Barts Health NHS Trust and private investors to unite clinical excellence and commercial innovation. Science Minister Lord Vallance said: “We have ambitious goals for making the UK Europe’s leader when it comes to life sciences’ sector-led investment in R&D, access to scale-up finance, and pulling in foreign direct investment....
Continue Reading
Join us for an exciting community event that opens the door to the world of life sciences
Aimed at college students (16+) and adults in the early stages of their Life Sciences career journeys, this event is your chance to explore career opportunities, meet industry experts, and take part in hands-on activities that bring science to life. If you are an employer, we invite you to showcase your achievements and engage with future talent. Why Attend as...
Continue Reading
Advancing Global Cancer Research at the Barts Cancer Institute: Driving innovation from lab to clinic in North East London
Cancer remains one of the world’s most complex health challenges, but in East London, collaboration is accelerating progress. The Barts Cancer Institute, based at Queen Mary University of London, is home to world-leading research in cancer biology and treatment. Within it, the Centre for Experimental Cancer Medicine – jointly embedded in Queen Mary and Barts Health NHS Trust – is...
Continue Reading
Barts Health and ABHI Partner to Accelerate HealthTech Innovation – A Boost for Barts Life Sciences
Barts Health NHS Trust has signed a new Memorandum of Understanding (MoU) with the Association of British HealthTech Industries (ABHI) to drive the adoption of cutting-edge health technologies that improve care, reduce health inequalities, and empower clinical teams. This collaboration aims to build a stronger health innovation cluster by bringing industry, academia, and frontline clinicians together to co-develop and scale...
Continue Reading
Leveraging technology to diversify clinical trial participation
Clinical trials often lack diversity with ethnic minorities being underrepresented. This imbalance can lead to treatments that are less effective for certain populations, reinforcing existing health inequalities. Caring for a population of around 2.5 million people representing 97 nations, Barts Health NHS Trust is well positioned to change this. Barts Health is already routinely capturing the diversity of research participants...
Continue Reading